NRI provides a comprehensive assessment of the added value of new biomarkers or risk factors. Traditional metrics like sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC) offer valuable insights, but they do not always capture the practical improvement in risk categorization. NRI complements these measures by focusing on the reclassification of individuals into clinically meaningful risk categories, thus making it highly relevant for decision-making in clinical practice.
